These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 8998957)
1. A generic toxicokinetic model for persistent lipophilic compounds in humans: an application to TCDD. van der Molen GW; Kooijman SA; Slob W Fundam Appl Toxicol; 1996 May; 31(1):83-94. PubMed ID: 8998957 [TBL] [Abstract][Full Text] [Related]
2. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and congeners in infants. A toxicokinetic model of human lifetime body burden by TCDD with special emphasis on its uptake by nutrition. Kreuzer PE; Csanády GA; Baur C; Kessler W; Päpke O; Greim H; Filser JG Arch Toxicol; 1997; 71(6):383-400. PubMed ID: 9195020 [TBL] [Abstract][Full Text] [Related]
3. The estimation of elimination rates of persistent compounds: a re-analysis of 2,3,7,8-tetrachlorodibenzo-p-dioxin levels in Vietnam veterans. van der Molen GW; Kooijman SA; Michalek JE; Slob W Chemosphere; 1998; 37(9-12):1833-44. PubMed ID: 9828312 [TBL] [Abstract][Full Text] [Related]
4. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633 [TBL] [Abstract][Full Text] [Related]
5. Concentration-dependent TCDD elimination kinetics in humans: toxicokinetic modeling for moderately to highly exposed adults from Seveso, Italy, and Vienna, Austria, and impact on dose estimates for the NIOSH cohort. Aylward LL; Brunet RC; Carrier G; Hays SM; Cushing CA; Needham LL; Patterson DG; Gerthoux PM; Brambilla P; Mocarelli P J Expo Anal Environ Epidemiol; 2005 Jan; 15(1):51-65. PubMed ID: 15083163 [TBL] [Abstract][Full Text] [Related]
6. Use of a physiologically based pharmacokinetic model for rats to study the influence of body fat mass and induction of CYP1A2 on the pharmacokinetics of TCDD. Emond C; Birnbaum LS; DeVito MJ Environ Health Perspect; 2006 Sep; 114(9):1394-400. PubMed ID: 16966094 [TBL] [Abstract][Full Text] [Related]
7. An adaptable internal dose model for risk assessment of dietary and soil dioxin exposures in young children. Kerger BD; Leung HW; Scott PK; Paustenbach DJ Toxicol Sci; 2007 Nov; 100(1):224-37. PubMed ID: 17682006 [TBL] [Abstract][Full Text] [Related]
8. Use of a toxicokinetic model in the analysis of cancer mortality in relation to the estimated absorbed dose of dioxin (2,3,7,8-tetrachlorodibenzo-p-dioxin, TCDD). Salvan A; Thomaseth K; Bortot P; Sartori N Sci Total Environ; 2001 Jul; 274(1-3):21-35. PubMed ID: 11453298 [TBL] [Abstract][Full Text] [Related]
10. Refinements on the age-dependent half-life model for estimating child body burdens of polychlorodibenzodioxins and dibenzofurans. Kerger BD; Leung HW; Scott PK; Paustenbach DJ Chemosphere; 2007 Apr; 67(9):S272-8. PubMed ID: 17207842 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of potential transmission of 2,3,7,8-tetrachlorodibenzo-p-dioxin-contaminated incinerator emissions to humans via foods. Fries GF; Paustenbach DJ J Toxicol Environ Health; 1990; 29(1):1-43. PubMed ID: 2405173 [TBL] [Abstract][Full Text] [Related]
13. Physiologically based pharmacokinetic model for developmental exposures to TCDD in the rat. Emond C; Birnbaum LS; DeVito MJ Toxicol Sci; 2004 Jul; 80(1):115-33. PubMed ID: 15056810 [TBL] [Abstract][Full Text] [Related]
14. The toxicological significance of 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds in human adipose tissue. Byard JL J Toxicol Environ Health; 1987; 22(4):381-403. PubMed ID: 3694702 [TBL] [Abstract][Full Text] [Related]
15. Estimation of occupational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin using a minimal physiologic toxicokinetic model. Thomaseth K; Salvan A Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):743-53. PubMed ID: 9599726 [TBL] [Abstract][Full Text] [Related]
16. Maturational changes in dermal absorption of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in Fischer 344 rats. Anderson YB; Jackson JA; Birnbaum LS Toxicol Appl Pharmacol; 1993 Apr; 119(2):214-20. PubMed ID: 8480330 [TBL] [Abstract][Full Text] [Related]
17. On the translation of uncertainty from toxicokinetic to toxicodynamic models--the TCDD example. Heinzl H; Mittlböck M; Edler L Chemosphere; 2007 Apr; 67(9):S365-74. PubMed ID: 17224175 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and biological activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. 1. Dose-dependent tissue distribution and induction of hepatic ethoxyresorufin O-deethylase in rats following a single injection. Abraham K; Krowke R; Neubert D Arch Toxicol; 1988; 62(5):359-68. PubMed ID: 3242446 [TBL] [Abstract][Full Text] [Related]
19. The distribution of [14C]-2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and its effect on the vitamin A content in parenchymal and stellate cells of rat liver. Håkansson H; Hanberg A J Nutr; 1989 Apr; 119(4):573-80. PubMed ID: 2703915 [TBL] [Abstract][Full Text] [Related]
20. A mechanistic model of effects of dioxin on thyroid hormones in the rat. Kohn MC; Sewall CH; Lucier GW; Portier CJ Toxicol Appl Pharmacol; 1996 Jan; 136(1):29-48. PubMed ID: 8560478 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]